A profit-thinner. Hospitals, docs await substitute for risky warfarin.
Becker
Cinda
C
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D001384:Azetidines; D001596:Benzylamines; D016527:Drug Costs; D016903:Drug Monitoring / Q000191:economics*; D006495:Heparin, Low-Molecular-Weight; D017721:Hospital Costs; D006801:Humans; D020521:Stroke / Q000517:prevention & control*; D014481:United States; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D006495:Heparin, Low-Molecular-Weight; C426686:ximelagatran; D014859:Warfarin